NCT00300443已完成2 期
Safety and Efficacy Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- Allergan
- 入组人数
- 561
- 试验地点
- 1
- 主要终点
- Lowering intraocular pressure (IOP)
研究概览
简要总结
The purpose of this study is to assess the safety and efficacy of bimatoprost in patients with glaucoma or ocular hypertension
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Clinical diagnosis of glaucoma or ocular hypertension in both eyes
- •Patient requires IOP-lowering drug in both eyes
排除标准
- •Uncontrolled medical conditions
- •Ocular seasonal allergies within the past 2 years
结局指标
主要结局
Lowering intraocular pressure (IOP)
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
3 期
A Safety Study of Bimatoprost in Patients With Glaucoma or Ocular HypertensionGlaucomaOcular HypertensionNCT01830140Allergan466
已完成
4 期
Safety and Efficacy of Bimatoprost Compared With Latanoprost in Patients With Glaucoma or Ocular HypertensionGlaucomaOcular HypertensionNCT00541242Allergan586
已完成
2 期
A Study of the Safety and Efficacy of Bimatoprost in Patients With Glaucoma or Ocular HypertensionGlaucomaOcular HypertensionNCT00538304Allergan222
已完成
3 期
Efficacy and Safety Study of Bimatoprost Sustained-Release (SR) in Participants With Open-angle Glaucoma or Ocular HypertensionGlaucoma, Open-AngleOcular HypertensionNCT02247804Allergan594
终止
3 期
A Study of the Safety and Efficacy of Bimatoprost Ophthalmic Solution in Paediatric Patients With GlaucomaGlaucomaNCT01426113Allergan6